Profound Medical Corp (PRN) Stock Price & News

PRN:TSE

Profound Medical Corp

CA$9.90

+1.33%

(+0.13) 1D

Nov 4, 4:00:00 PM GMT-5 · CAD

All symbols

	Symbol	Price	Change	% Change

Next call in 23:04:18

Tomorrow, 4:30 PM

Fiscal period

Q3 2026

- / -CA$0.27

Revenue / Est. (CAD)

- / 13.81M

Fiscal Q3 2026 earnings call

Waiting for the earnings call

At a glance: upcoming earnings

Insights from the latest news and reports

Previous reportsAll values in CAD

Loading Previous Earnings...

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	5.29M	5.98M	5.34M	2.48M
Cost of goods sold	1.36M	1.99M	1.50M	536.00K
Cost of revenue	1.36M	1.99M	1.50M	536.00K
Research and development expenses	5.42M	4.27M	5.26M	5.65M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	7.43M	7.09M	6.59M	7.36M
Operating expense	12.84M	11.36M	11.85M	13.01M
Total operating expenses	14.20M	13.35M	13.36M	13.55M
Operating income	-8.91M	-7.37M	-8.02M	-11.07M
Other non operating income	-	-	-	-
EBT including unusual items	-7.86M	-8.15M	-7.03M	-9.48M
EBT excluding unusual items	-7.86M	-8.15M	-7.03M	-9.48M
Income tax expense	121.00K	26.00K	25.00K	55.00K
Effective tax rate	-1.54%	-0.32%	-0.36%	-0.58%
Other operating expenses	-	-	-	-
Net income	-7.98M	-8.18M	-7.05M	-9.54M
Net profit margin	-150.82%	-136.77%	-132.15%	-384.21%
Earnings per share	-	-	-	-0.26
Interest and investment income	122.00K	160.00K	377.00K	336.00K
Interest expense	-	-	-	-
Net interest expenses	122.00K	160.00K	377.00K	336.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-8.77M	-7.26M	-7.92M	-10.93M
Gain or loss from assets sale	-	-	-	-

Finance